Explore

Innovations

                                        
                                    Published
                            
                Healthcare & Pharmaceuticals
            
Novel CYP26A1 Inhibitors
                A series of compounds was synthesized using rational drug-based design. These compounds represent significant improvements over other clinically tested CYP26 antagonists.
            
By
                            Queen’s University
                        
Reference Number  
                09233
            
Last Update  
                 Sep 15, 2022
            
                                    Published
                            
                Healthcare & Pharmaceuticals
            
Selective Cyp26 Antagonists
                Cyp26 inhibitor compounds treat diseases such as psoriasis, while avoiding retinoid related side effects
            
By
                            Queen’s University
                        
Reference Number  
                07177
            
Last Update  
                 Jul 20, 2021
            
Do you have an innovative technology, product or service?
            Add your solution to the world’s most advanced open innovation platform and get seen by global corporations seeking new solutions – all free of charge.

View all

Keep your eye on the ball, subscribe to our email marketing to stay up to date with LEO.